| MedAvante Risk Reduction for CNS Trials | |
| MedAvante’s primary focus is on bringing certainty to assessments performed during CNS trials. Current assessment methods employ highly subjective rating instruments to: Evaluate whether a potential participant meets protocol-specified inclusi | |
| Keywords : CNS, clinical trial, central ratings, depression, mood, anxiety, psychiatric scales, drug testing, assessments |
| Last Update : | 02/January/2012 |
| Google PR : | N/A |
| Internal links : | 20 |
| External links : | 3 |
| Archive : | Check how did the site look in the past? |